This product is no longer in stock
ELIQUIS (apixaban) is prescribed to reduce the likelihood of systemic embolism and stroke in patients with NVAF (non-valvular atrial fibrillation).
ELIQUIS is contraindicated in people with such diseases as:
• clinically significant bleeding and adverse reactions; • hypersensitivity to apixaban (anaphylactic reactions).
Sometimes abolition of ELIQUIS treatment can cause a stroke. In addition, discontinuing drug use (without adequate alternative anticoagulation) increases the risk of thrombotic events. Clinical studies have shown that transition from ELIQUIS to warfarin provokes a risk of stroke in patients with non-valvular atrial fibrillation. If you need to stop taking ELIQUIS, you should choose another anticoagulant.
Do not take ELIQUIS if you:
If you have any doubts, you should consult a specialist.
Almost all serious side effects caused by the use of ELIQUIS were associated with bleeding.
ELIQUIS can cause a skin rash or a strong allergic reaction. Contact your doctor or get emergency care if you have any of the following signs:
Store below 30°C.
Bristol-Myers Squibb, Italia.
148 31 3349600/01
Similar medications: Apixaban, Betrixaban, Darexaban, Edoxaban, Lixiana, Savaysa, Otamixaban, Rivaroxaban, Xarelto
Buy Eliquis 2.5 mg 60 tablets / Buy Eliquis 2.5 mg online / Eliquis 2.5 mg 60 tablets original / Delivery Eliquis 2.5 mg worldwide
Buy Apixaban 2.5 mg 60 tablets / Buy Apixaban 2.5 mg online / Apixaban 2.5 mg 60 tablets original / Delivery Apixaban 2.5 mg worldwide
Buy Rivaroxaban tablets / VBuy Apixaban online / Betrixaban tablets original / Delivery Edoxaban worldwide